Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer (Q43160126)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer |
scientific article published in October 2009 |
Statements
1 reference
Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer (English)
1 reference
Hassan Errihani
1 reference
Hind Mrabti
1 reference
Christelle De la Fouchardiere
1 reference
Francoise Desseigne
1 reference
Sophie Dussart
1 reference
Sylvie Negrier
1 reference
1 October 2009
1 reference
1 reference
5
1 reference
4
1 reference
272-276
1 reference
Identifiers
1 reference
1 reference